Agenda
7:15 AM
Registration & Breakfast
8:15 AM
8:30 AM
Leadership Across Eras in the Biopharma Industry
Severin Schwan, Roche Holding
Hosted by Christopher Hite, Royalty Pharma
9:00 AM
From Cancer to Autoimmunity: The Expanding Frontier of T-Cell Redirecting Therapies
Ricardo Grieshaber-Bouyer, FAU Erlangen-Nürnberg
9:15 AM
Outlook on UK Innovation and Role In World
Lord Patrick Vallance, UK Department for Science, Innovation and Technology (DSIT)
Hosted by Kate Bingham, SV Health Managers
9:35 AM
Public Investor Panel: Sentiment Has Improved - But What Sustains It?
Andy Acker, Janus Henderson Investors
Judith Finegold, Capital Group
Kris Jenner, Rock Springs Capital
Moderated by Terry Coyne, Royalty Pharma
10:10 AM
Refreshment Break
10:35 AM
Building a Revolution to Outsmart RAS Cancers
Mark Goldsmith, Revolution Medicines
Margaret (Peg) Horn, Revolution Medicines
Hosted by Marshall Urist, Royalty Pharma
11:00 AM
Taking the Pulse on Strategic Deal Making
Andrew Baum, Pfizer
Chris Sheldon, GSK
Otello Stampacchia, Omega Funds
Moderated by Mary Lynne Hedley, Third Rock Ventures; Broad Institute
11:35 AM
From Breakthrough Science to Global Biopharma
Yvonne Greenstreet, Alnylam
Hosted by Richard Mason, Apollo Therapeutics
12:00 PM
Protein Folding, Persistence, and a 25-Year Overnight Success
Jeffery Kelly, The Scripps Research Institute
12:20 PM
Designing and Translating Nanomaterials for Next Generation Therapeutics
Dame Molly Stevens, University of Oxford
12:35 PM
Lunch
1:35 PM
Builders, Buyers, and the Blurring Line Between Private Capital and Pharma
Francesco De Rubertis, Medicxi
Simeon George, SR One
Adam Koppel, Bain Capital
Moderated by Matthias Müllenbeck, Merck KGaA
2:10 PM
From O2 Sensing to Drugging the Undruggable
William Kaelin, 2019 Nobel Laureate, Harvard Medical School
Hosted by Siddhartha Mukherjee, 2011 Pulitzer Prize, Columbia University & Manas AI
2:35 PM
Constructing Life: Programming Cells to Manufacture New Medicines
Ola Wlodek, Constructive Bio
2:50 PM
Reimagining Atopic Disease Through STAT6 Degradation
Nello Mainolfi, Kymera Therapeutics
3:05 PM
Concert Lecture: The Mind and Music of the World’s Most Transformative Composer
Richard Kogan, Weill Cornell Medicine
3:30 PM
Refreshment Break
3:55 PM
R&D: Disruption, New World Orders, and Opportunity
Jay Bradner, Amgen
Jane Grogan, Biogen
Christian Rommel, Bayer Pharmaceuticals
Moderated by Jim Reddoch, Royalty Pharma
4:30 PM
Pioneering an Integrated In Vivo CAR-T Cell Therapy Platform
Andrew Scharenberg, Umoja Biopharma
4:45 PM
Beyond GLP-1: Rethinking the Foundations of Obesity Innovation
Sir Stephen O’Rahilly, University of Cambridge
Hosted by Ethan Weiss, Marea
5:10 PM
Legends of Innovation: Building and Scaling Biotech Giants
Bob Hugin, Celgene Corporation (retired)
John F. Milligan, Gilead Sciences
Hosted by Christopher Hite, Royalty Pharma
5:35 PM
Closing Remarks
6:00 PM
King’s Chapel, Seated Dinner, and Entertainment
King’s College, University of Cambridge
* Dress Code: Business casual
Welcome
Patrick Maxwell, University of Cambridge
Making Decisions in an Age of Uncertainty
Sir David Spiegelhalter, University of Cambridge
Introduction by Sir John Aston, University of Cambridge
The Gentlemen of St John’s Choir
10:00 PM
Café Society: An Après at the Graduate
Color Key:
Fireside Chat
Short talk
Panel
Remarks
Activity
*Times subject to change